OctPGMS pathway control state: Difference between revisions
From Bioblast
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
'''MitoPathway control:''' CI<small>&</small>II<small>&</small>FAO | '''MitoPathway control:''' CI<small>&</small>II<small>&</small>FAO | ||
'''SUIT protocol:''' [[SUIT | '''SUIT protocol:''' [[SUIT RP1]], [[SUIT RP2]] | ||
This substrate combination supports convergent electron flow to the [[Q-junction]]. | This substrate combination supports convergent electron flow to the [[Q-junction]]. | ||
Revision as of 12:16, 20 July 2016
- high-resolution terminology - matching measurements at high-resolution
OctPGMS pathway control state
Description
PGMSOct: Pyruvate & Glutamate & Malate & Succinate & Octanoylcarnitine.
MitoPathway control: CI&II&FAO
SUIT protocol: SUIT RP1, SUIT RP2
This substrate combination supports convergent electron flow to the Q-junction.
Abbreviation: PGMSOct
Reference: MiPNet21.06 SUIT reference protocol, SUIT reference protocol
MitoPedia concepts:
Respiratory state,
SUIT state
PGMSOct(L)
PGMSOct(P)
- SUIT RP2_6S: 1D 2Oct 3Mtit 3c (3NADH) 4P 5G 6S 7U 8Gp 9Rot 10Ama 11Tm 12Azd
PGMSOct(E)
- SUIT RP1_6S: 1PM 2D 2c (2NADH) 3U 4Oct 5G 6S 7Rot 8Gp 9Ama 10Tm 11Azd
- SUIT RP2_7U: 1D 2Oct 3Mtit 3c (3NADH) 4P 5G 6S 7U 8Gp 9Rot 10Ama 11Tm 12Azd
